| Starting Price | Not public; implementation + annual licensing noted for some modules | Not public (enterprise) | Bundled/variable with EHR contract; depends on modules |
| Most appropriate for | Hospitals seeking pharmacy-led surveillance with ONC-certified AUR reporting and a multi-module suite (pharmacy surveillance, drug diversion, infection prevention) | Organizations prioritizing an established surveillance vendor with a long market presence | MEDITECH customer organizations aiming to use EHR-native toolkits to reduce external integrations |
| Key strength | Vendor disclosures for ONC certification for AUR reporting; platform approach for multiple modules | Long-standing presence in pharmacy surveillance and stewardship evaluations | Integrated within the core EHR environment, which can reduce integration work in some cases |
| Key weakness | Limited transparent third-party review content publicly available; pricing opacity; outcomes depend on data quality and rule tuning | Pricing opacity and integration/governance requirements similar to other enterprise products | Native toolkits may be less feature-rich than dedicated best-of-breed platforms in some functional areas |